ACT Capital Management’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

ACT Capital Management’s Portfolio MDNA Stock Details MDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$124K	Hold	149,070	–	–	0.17%	47
2022 Q2	$173K	Sell	149,070 -3,430	-2%	-$3.67K	0.24%	42
2022 Q1	$195K	Hold	152,500	–	–	0.21%	50
2021 Q4	$249K	Sell	152,500 -197,500	-56%	-$410K	0.18%	61
2021 Q3	$970K	Hold	350,000	–	–	0.5%	37
2021 Q2	$1.05M	Buy	+350,000	New	+$1.29M	0.54%	38

Other funds holding MDNA

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

ACT Capital Management's MDNA Position: Q3 2022 in Review

ACT Capital Management held its Medicenna Therapeutics Corp. Common Shares (MDNA) position steady in Q3 2022 at 149,070 shares worth $124K. The position accounts for 0.17% of the portfolio, ranked #47.

ACT Capital Management first reported a position in MDNA in Q2 2021 and has held it in 6 quarters since. The position peaked at $1.05M in Q2 2021. 28 funds tracked by Wall St. Rank hold MDNA as of Q3 2022.

ACT Capital Management held 149,070 shares of Medicenna Therapeutics Corp. Common Shares worth $124K as of Q3 2022.
ACT Capital Management left its Medicenna Therapeutics Corp. Common Shares share count unchanged in Q3 2022.
Medicenna Therapeutics Corp. Common Shares made up 0.17% of ACT Capital Management's portfolio in Q3 2022, its #47 holding.
ACT Capital Management first reported a position in Medicenna Therapeutics Corp. Common Shares in Q2 2021 and has held it in 6 quarters since.
ACT Capital Management's Medicenna Therapeutics Corp. Common Shares position peaked at $1.05M in Q2 2021.
28 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q3 2022.

Based on ACT Capital Management's 13F filing for Q3 2022, filed 3 Nov 2022.